NCT07882277Not yet recruiting
27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer Surgery
Effect of 27-Inch and 55-Inch Endoscopic Imaging Monitors on Surgical and Postoperative Outcomes in Endometrial Cancer Surgery: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
This study will compare the use of 27-inch and 55-inch endoscopic imaging monitors during minimally invasive surgery for women with endometrial cancer. Participants will be randomly assigned to one of the two monitor groups. All participants will undergo the same standard surgical procedure; only the monitor size used during surgery will differ. The main question is whether monitor size affects total operative time. The study will also evaluate sentinel lymph node dissection time, blood count changes, complications, infections, hospital stay, and drain-related outcomes during the first 30 days after surgery.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 6 Oct 2026
- Start date
- Oct 2026
- Primary completion date
- Jan 2028
- Lead sponsor
- Metehan Uzundal
- Diseases
- Endometrial cancer
- NCT number
- NCT07882277
What you commit to
- Study type: Interventional
- Planned participants: 70
- From Oct 2026 to the primary completion date, Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Need for an additional major surgical procedure outside the standardized surgical protocol
Other illness
- Not suitable for minimally invasive surgery, such as severe cardiopulmonary disease
- Failure of bilateral sentinel lymph node mapping or inability to perform bilateral sentinel lymph node dissection
- History of abdominal surgery through a midline incision
- History of myomectomy
- History of tubo-ovarian abscess
- History of three or more cesarean deliveries
Lab values
- Preoperative hemoglobin level below 10 g/dL
Other
- Distant metastasis detected on preoperative imaging or clinical evaluation
- Conversion from laparoscopy to laparotomy
- Systematic pelvic and/or para-aortic lymph node dissection performed
- Body mass index of 40 kg/m² or higher
- Uterine size equivalent to 12 weeks of gestation or larger
- Dense bowel or omental adhesions detected intraoperatively
- Refusal to participate or inability to provide informed consent
Who the study is looking for
- Female patients aged 18 years or older
- Histologically diagnosed endometrial cancer with planned surgical treatment
- Eligible for minimally invasive surgery
- Planned total laparoscopic hysterectomy with bilateral salpingectomy or bilateral salpingo-oophorectomy and sentinel lymph node dissection
- No severe systemic disease that would contraindicate laparoscopic surgery based on preoperative evaluation
- Standard cervical four-quadrant indocyanine green injection planned for sentinel lymph node mapping
- Bilateral sentinel lymph node mapping and bilateral sentinel lymph node dissection feasible during surgery
- Preoperative hemoglobin level of 10 g/dL or higher
- Able and willing to provide written informed consent
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Başakşehir Çam and Sakura City Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.